82 results on '"Rothberg, Michael B."'
Search Results
2. Realistic digital phantoms for prostate ultrasound and photoacoustic imaging
- Author
-
Boehm, Christian, Bottenus, Nick, Wu, Yixuan, Enders, Jacob, Williams, Cheyenne, Jiang, Baichuan, Wiskin, James, Rothberg, Michael B., Negussie, Ayele H., Klock, John, Hazen, Lindsey, Xu, Sheng, Turkbey, Baris, Pinto, Peter A., Wood, Bradford J., and Boctor, Emad M.
- Published
- 2024
- Full Text
- View/download PDF
3. Derivation and validation of a risk assessment model for drug-resistant pathogens in hospitalized patients with community-acquired pneumonia
- Author
-
Rothberg, Michael B., Haessler, Sarah, Deshpande, Abhishek, Yu, Pei-Chun, Lindenauer, Peter K., Zilberberg, Marya D., Higgins, Thomas L., and Imrey, Peter B.
- Abstract
AbstractObjective:To derive and validate a model for risk of resistance to first-line community-acquired pneumonia (CAP) therapy.Design:We developed a logistic regression prediction model from a large multihospital discharge database and validated it versus the Drug Resistance in Pneumonia (DRIP) score in a holdout sample and another hospital system outside that database. Resistance to first-line CAP therapy (quinolone or third generation cephalosporin plus macrolide) was based on blood or respiratory cultures.Setting:This study was conducted using data from 177 Premier Healthcare database hospitals and 11 Cleveland Clinic hospitals.Participants:Adults hospitalized for CAP.Exposure:Risk factors for resistant infection.Results:Among 138,762 eligible patients in the Premier database, 12,181 (8.8%) had positive cultures and 5,200 (3.8%) had organisms resistant to CAP therapy. Infection with a resistant organism in the previous year was the strongest predictor of resistance; markers of acute illness (eg, receipt of mechanical ventilation or vasopressors) and chronic illness (eg, pressure ulcer, paralysis) were also associated with resistant infections. Our model outperformed the DRIP score with a C-statistic of 0.71 versus 0.63 for the DRIP score (P< .001) in the Premier holdout sample, and 0.65 versus 0.58 (P< .001) in Cleveland Clinic hospitals. Clinicians at Premier facilities used broad-spectrum antibiotics for 20%–30% of patients. In discriminating between patients with and without resistant infections, physician judgment slightly outperformed the DRIP instrument but not our model.Conclusions:Our model predicting infection with a resistant pathogen outperformed both the DRIP score and physician practice in an external validation set. Its integration into practice could reduce unnecessary use of broad-spectrum antibiotics.
- Published
- 2023
- Full Text
- View/download PDF
4. Frequency of Use and Outcomes of Colonoscopy in Individuals Older Than 75 Years
- Author
-
El Halabi, Jessica, Burke, Carol A., Hariri, Essa, Rizk, Maged, Macaron, Carole, McMichael, John, and Rothberg, Michael B.
- Abstract
IMPORTANCE: The benefits from colorectal cancer (CRC) screening may take 10 to 15 years to accrue. Therefore, screening is recommended for older adults who are in good health. OBJECTIVE: To determine the number of screening colonoscopies done in patients older than 75 years with a life expectancy of fewer than 10 years, diagnostic yield, and associated adverse events within 10 days and 30 days of the procedure. DESIGN: This cross-sectional study with a nested cohort between January 2009 and January 2022 in an integrated health system assessed asymptomatic patients older than 75 years who underwent screening colonoscopy in the outpatient setting. Reports with incomplete data, any indication other than screening, patients who had a colonoscopy within the previous 5 years, and patients with a personal history of inflammatory bowel disease or CRC were excluded. EXPOSURES: Life expectancy based on a prediction model from previous literature. MAIN OUTCOMES AND MEASURES: The primary outcome was the percentage of screened patients who had limited (<10 years) life expectancy. Other outcomes included colonoscopy findings and adverse events that developed within 10 days and 30 days of the procedure. RESULTS: A total of 7067 patients older than 75 years were included. The median (IQR) age was 78 (77-79) years, 3967 (56%) were women, and 5431 (77%) were White with an average of 2 comorbidities (taken from a select group of comorbidities). The proportion of colonoscopies performed on patients with a life expectancy of fewer than 10 years aged 76 to 80 years was 30% in both sexes and increased with age—82% of men and 61% of women aged 81 to 85 years (71% total), and 100% of patients beyond the age of 85 years. Adverse events requiring hospitalizations were common at 10 days (13.58 per 1000) and increased with age, particularly among patients older than 85 years. The detection of advanced neoplasia varied from 5.4% among patients aged 76 to 80 years to 6.2% in those aged 81 to 85 years and 9.5% among patients older than 85 years (P = .02). Of the total population, 15 patients (0.2%) had invasive adenocarcinoma; among patients with a life expectancy of fewer than 10 years, 1 of 9 was treated, whereas 4 of 6 patients with a life expectancy of greater than or equal to 10 years were treated. CONCLUSIONS AND RELEVANCE: In this cross-sectional study with a nested cohort, most screening colonoscopies performed in patients older than 75 years were in patients with limited life expectancy and associated with increased risk of complications. Colorectal cancer was exceedingly rare.
- Published
- 2023
- Full Text
- View/download PDF
5. Long-term Outcomes of a 1-year Hypertension Quality Improvement Initiative in a Large Health System
- Author
-
Pfoh, Elizabeth R., Dalton, Jarrod, Jones, Robert, and Rothberg, Michael B.
- Published
- 2023
- Full Text
- View/download PDF
6. Medical scribes: how do their notes stack up?
- Author
-
Misra-Hebert, Anita D., Amah, Linda, Rabovsky, Andrew, Morrison, Shannon, Cantave, Marven, Sinsky, Christine A., and Rothberg, Michael B.
- Subjects
Medical records -- Management ,Medical writing -- Methods ,Company business management ,Health - Abstract
ABSTRACT Objective Medical scribes are increasingly employed to improve physician efficiency with regard to the electronic medical record (EMR). The impact of scribes on the quality of outpatient visit notes [...]
- Published
- 2016
7. Association of fluoroquinolones or cephalosporin plus macrolide with Clostridioides difficileinfection (CDI) after treatment for community-acquired pneumonia
- Author
-
Patel, Preethi, Deshpande, Abhishek, Yu, Pei-Chun, Imrey, Peter B., Lindenauer, Peter K., Zilberberg, Marya D., Haessler, Sarah, and Rothberg, Michael B.
- Abstract
AbstractObjective:Clostridioides difficileinfection (CDI) is the most common cause of gastroenteritis, and community-acquired pneumonia (CAP) is the most common infection treated in hospitals. American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) CAP guidelines recommend empiric therapy with a respiratory fluoroquinolone or cephalosporin plus macrolide combination, but the CDI risk of these regimens is unknown. We examined the association between each antibiotic regimen and the development of hospital-onset CDI.Methods:We conducted a retrospective cohort study using data from 638 US hospitals contributing administrative including 177 also contributing microbiologic data to Premier, Inc. We included adults admitted with pneumonia and discharged from July 2010 through June 2015 with a pneumonia diagnosis code who received ≥3 days of either empiric regimen. Hospital-onset CDI was defined by a diagnosis code not present on admission and positive laboratory test on day 4 or later or readmission for CDI. Mixed propensity-weighted multiple logistic regression was used to estimate the associations of CDI with antibiotic regimens.Results:Our sample included 58,060 patients treated with either cephalosporin plus macrolide (36,796 patients) or a fluoroquinolone alone (21,264 patients) and with microbiological data; 127 (0.35%) patients who received cephalosporin plus macrolide and 65 (0.31%) who received a fluoroquinolone developed CDI. After adjustment for patient demographics, comorbidities, risk factors for antimicrobial resistance, and hospital characteristics, CDI risks were similar for fluoroquinolones versus cephalosporin plus macrolide (odds ratio [OR], 0.98; 95% confidence interval [CI], 0.70–1.38).Conclusion:Among patients with CAP at US hospitals, CDI was uncommon, occurring in ∼0.33% of patients. We did not detect a significant association between the choice of empiric guideline recommended antibiotic therapy and the development of CDI.
- Published
- 2023
- Full Text
- View/download PDF
8. Qualitative Analysis of Patient–Physician Discussions Regarding Anticoagulation for Atrial Fibrillation
- Author
-
Martinez, Kathryn A., Hurwitz, Heather McKee, and Rothberg, Michael B.
- Abstract
IMPORTANCE: For patients with atrial fibrillation (AF), the decision to initiate anticoagulation involves the choice between warfarin or a direct oral anticoagulant (DOAC). How physicians engage patients in this decision is unknown. OBJECTIVE: To describe the content of discussions between patients with AF and physicians regarding choice of anticoagulation. DESIGN, SETTING, AND PARTICIPANTS: This qualitative content analysis included clinical encounters between physicians and anticoagulation-naive patients discussing anticoagulation initiation between 2014 and 2020. MAIN OUTCOMES AND MEASURES: Themes identified through content analysis. RESULTS: Of 37 encounters, almost all (34 [92%]) resulted in a prescription for a DOAC. Most (25 [68%]) patients were White; 15 (41%) were female and 22 (59%) were male; and 24 (65%) were aged 65 to 84 years. Twenty-one physicians conducted the included encounters, the majority of whom were cardiologists (14 [67%]) and male (19 [90%]). The analysis revealed 4 major categories and associated subcategories of themes associated with physician discussion of anticoagulation with anticoagulation-naive patients: (1) benefit vs risk of taking anticoagulation—in many cases, this involved an imbalance in completeness of discussion of stroke vs bleeding risk, and physicians often used emotional language; (2) tradeoffs between warfarin and DOACs—physicians typically discussed pros and cons, used persuasive language, and provided mixed signals, telling patients that warfarin and DOACs were basically equivalent, while simultaneously saying warfarin is rat poison; (3) medication costs—physicians often attempted to address patients’ questions about out-of-pocket costs but were unable to provide concrete answers, and they often provided free samples or coupons; and (4) DOACs in television commercials—physicians used direct-to-consumer pharmaceutical advertising about DOACs to orient patients to the issue of anticoagulation as well as the advantages of DOACs over warfarin. Patients and physicians also discussed class action lawsuits for DOACs that patients had seen on television. CONCLUSIONS AND RELEVANCE: This qualitative analysis of anticoagulation discussions between physicians and patients during clinical encounters found that physicians engaged in persuasive communication to convince patients to accept anticoagulation with a DOAC, yet they were unable to address questions regarding medication costs. For patients who are ultimately unable to afford DOACs, this may lead to unnecessary financial burden or abandoning prescriptions at the pharmacy, placing them at continued risk of stroke.
- Published
- 2022
- Full Text
- View/download PDF
9. Trends, Distribution, and Impact of Pediatric Messages in a Large Health System From 2019 to 2021
- Author
-
Tang, Maria C., Martinez, Kathryn A., Rothberg, Michael B., Giuliano, Kimberly, and Pfoh, Elizabeth R.
- Published
- 2023
- Full Text
- View/download PDF
10. Influenza Testing and Treatment Among Patients Hospitalized With Community-Acquired Pneumonia
- Author
-
Deshpande, Abhishek, Klompas, Michael, Yu, Pei-Chun, Imrey, Peter B., Pallotta, Andrea M., Higgins, Thomas, Haessler, Sarah, Zilberberg, Marya D., Lindenauer, Peter K., and Rothberg, Michael B.
- Abstract
Influenza is a leading cause of community-acquired pneumonia (CAP), and results of influenza tests can direct therapy. However, among adults hospitalized with CAP, little is known about the frequency and timing of influenza testing, treatment, and their associations with outcomes.
- Published
- 2022
- Full Text
- View/download PDF
11. Derivation and Validation of a Risk Factor Model to Identify Medical Inpatients at Risk for Venous Thromboembolism
- Author
-
Rothberg, Michael B., Hamilton, Aaron C., Greene, M. Todd, Fox, Jacqueline, Lisheba, Oleg, Milinovich, Alex, Gautier, Thomas N., Kim, Priscilla, Kaatz, Scott, and Hu, Bo
- Published
- 2022
- Full Text
- View/download PDF
12. Association of Physical Therapy Treatment Frequency in the Acute Care Hospital With Improving Functional Status and Discharging Home
- Author
-
Johnson, Joshua K., Rothberg, Michael B., Adams, Kellie, Lapin, Brittany, Keeney, Tamra, Stilphen, Mary, Bethoux, Francois, and Freburger, Janet K.
- Published
- 2022
- Full Text
- View/download PDF
13. Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease
- Author
-
Rothberg, Michael B., Sivalingam, Senthil K., Ashraf, Javed, Visintainer, Paul, Joelson, John, Kleppel, Reva, Vallurupalli, Neelima, and Schweiger, Marc J.
- Subjects
Cardiovascular system -- Surgery ,Cardiovascular system -- Health aspects ,Cardiovascular system -- Patient outcomes ,Cardiovascular system -- Research ,Coronary heart disease -- Care and treatment ,Coronary heart disease -- Patient outcomes ,Coronary heart disease -- Research ,Health - Abstract
Background: It is unclear whether patients understand that percutaneous coronary intervention (PCI) reduces only chronic stable angina and not myocardial infarction (MI) or associated mortality. Objective: To compare cardiologists' and patients' beliefs about PCI. Design: Survey. Setting: Academic center. Participants: 153 patients who consented to elective coronary catheterization and possible PCI, 10 interventional cardiologists, and 17 referring cardiologists. Measurements: Patients' and cardiologists' beliefs about benefits of PCI. All cardiologists reported beliefs about PCI for patients in hypothetical scenarios. Interventional cardiologists also reported beliefs for study patients who underwent PCI. Results: Of 153 patients, 68% had any angina, 42% had activity-limiting angina, 77% had a positive stress test result, and 29% had had previous MI. The 53 patients who underwent PCI were more likely than those who did not to have a positive stress test result, but angina was similar in both groups. Almost three quarters of patients thought that without PCI, they would probably have MI within 5 years, and 88% believed that PCI would reduce risk for MI. Patients were more likely than physicians to believe that PCI would prevent MI (prevalence ratio, 4.25 [95% CI, 2.31 to 7.79]) or fatal MI (prevalence ratio, 4.83 [CI, 2.23 to 10.46]). Patients were less likely than their physicians to report pre-PCI angina (prevalence ratio, 0.79 [CI, 0.67 to 0.92]). For the scenarios, 63% of cardiologists believed that the benefits of PCI were limited to symptom relief. Of cardiologists who identified no benefit of PCI in 2 scenarios, 43% indicated that they would still proceed with PCI in these cases. Limitation: The study was small and conducted at 1 center, and information about precatheterization counseling was limited. Conclusion: Cardiologists' beliefs about PCI reflect trial results, but patients' beliefs do not. Discussions with patients before PCI should better explain anticipated benefits. Primary Funding Source: None.
- Published
- 2010
14. Case volume, quality of care, and care efficiency in coronary artery bypass surgery
- Author
-
Auerbach, Andrew D., Hilton, Joan F., Maselli, Judith, Pekow, Penelope S., Rothberg, Michael B., and Lindenauer, Peter K.
- Subjects
Coronary artery bypass -- Patient outcomes ,Coronary artery bypass -- Quality management ,Coronary artery bypass -- Research ,Outcome and process assessment (Health Care) -- Research ,Medical care -- Quality management ,Medical care -- Research ,Hospitals -- Admission and discharge ,Hospitals -- Research ,Health - Published
- 2010
15. Shop for quality or volume? Volume, quality, and outcomes of coronary artery bypass surgery
- Author
-
Auerbach, Andrew D., Hilton, Joan F., Maselli, Judith, Pekow, Penelope S., Rothberg, Michael B., and Lindenauer, Peter K.
- Subjects
Coronary artery bypass -- Health aspects ,Coronary artery bypass -- Patient outcomes ,Mortality -- Risk factors ,Mortality -- Control ,Medical care -- Quality management ,Medical care -- Research ,Health - Abstract
Background: Care from high-volume centers or surgeons has been associated with lower mortality rates in coronary artery bypass surgery, but how volume and quality of care relate to each other is not well understood. Objective: To determine how volume and differences in quality of care influence outcomes after coronary artery bypass surgery. Design: Observational cohort. Setting: 164 hospitals in the United States. Patients: 81 289 patients 18 years or older who had coronary artery bypass grafting from 1 October 2003 to 1 September 2005. Measurements: Hospital and surgeon case volumes were estimated by using a data set. Quality measures were defined by whether patients received specific medications and by counting the number of measures missed. Hierarchical models were used to estimate effects of volume and quality on death and readmission up to 30 days. Results: After adjustment for clinical factors, lowest surgeon volume and highest hospital volume were associated with higher mortality rates and lower readmission risk, respectively. Patients who did not receive aspirin (odds ratio, 1.89 [95% CI, 1.65 to 2.16) or [beta]-blockers (odds ratio, 1.29 [CI, 1.12 to 1.49]) had higher odds for death, after adjustment for clinical risk factors and case volume. Adjustment for individual quality measures did not alter associations between volume and readmission or death. However, if no quality measures were missed, mortality rates at the lowest-volume centers (adjusted mortality rate, 1.05% [CI, 0.81% to 1.29%]) and highest-volume centers (adjusted mortality rate, 0.98% [CI, 0.72% to 1.25%]) were similar. Limitation: Because administrative data were used, the quality measures may not replicate measures collected through chart abstraction. Conclusion: Maximizing adherence to quality measures is associated with improved mortality rates, independent of hospital or surgeon volume. Primary Funding Source: California HealthCare Foundation.
- Published
- 2009
16. The role of novel imaging in prostate cancer focal therapy: treatment and follow-up
- Author
-
Rothberg, Michael B., Enders, Jacob J., Kozel, Zachary, Gopal, Nikhil, Turkbey, Baris, and Pinto, Peter A.
- Published
- 2022
- Full Text
- View/download PDF
17. Reduced Cognitive Burden and Increased Focus
- Author
-
Pfoh, Elizabeth R., Hong, Sandra, Baranek, Laura, Rothberg, Michael B., Beinkampen, Sarah, Misra-Hebert, Anita D., Rehm, Susan J., and Sikon, Andrea L.
- Published
- 2022
- Full Text
- View/download PDF
18. Complications of Viral Influenza
- Author
-
Rothberg, Michael B., Haessler, Sarah D., and Brown, Richard B.
- Subjects
Influenza -- Care and treatment ,Influenza -- Prevention ,Influenza -- Complications and side effects ,Influenza -- Research ,Health ,Health care industry - Abstract
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.amjmed.2007.10.040 Byline: Michael B. Rothberg (a)(c), Sarah D. Haessler (b)(c), Richard B. Brown (b)(c) Keywords: Antiviral therapy; Complications; Influenza; Pneumonia; Vaccination Abstract: Viral influenza is a seasonal infection associated with significant morbidity and mortality. In the United States more than 35,000 deaths and 200,000 hospitalizations due to influenza occur annually, and the number is increasing. Children aged less than 1 year and adults aged more than 65 years, pregnant woman, and people of any age with comorbid illnesses are at highest risk. Annual vaccination is the cornerstone of prevention, but some older patients may derive less benefit from immunization than otherwise fit individuals. If started promptly, antiviral medications may reduce complications of acute influenza, but increasing resistance to amantadine and perhaps neuraminidase inhibitors underscores the need for novel prevention and treatment strategies. Pulmonary complications of influenza are most common and include primary influenza and secondary bacterial infection. Either may cause pneumonia, and each has a unique clinical presentation and pathologic basis. Staphylococcus aureus, including methicillin-resistant strains, is an important cause of secondary bacterial pneumonia with high mortality. During influenza season, treatment of pneumonia should include empiric coverage for this pathogen. Neuromuscular and cardiac complications are unusual but may manifest in persons of any age. Author Affiliation: (a) Division of General Medicine, Baystate Medical Center, Springfield, Mass (b) Division of Infectious Diseases, Baystate Medical Center, Springfield, Mass (c) Tufts University School of Medicine, Boston, Mass.
- Published
- 2008
19. Management of influenza symptoms in healthy children: cost-effectiveness of rapid testing and antiviral therapy
- Author
-
Rothberg, Michael B., Fisher, Donna, Kelly, Brendan, and Rose, David N.
- Subjects
Influenza -- Care and treatment ,Antiviral agents -- Economic aspects ,Medical tests -- Economic aspects ,Cost benefit analysis -- Research ,Pediatric respiratory diseases -- Care and treatment ,Cost benefit analysis ,Health - Published
- 2005
20. Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit
- Author
-
Rothberg, Michael B., Celestin, Carmel, Fiore, Louis D., Lawler, Elizabeth, and Cook, James R.
- Subjects
Aspirin -- Health aspects ,Aspirin -- Comparative analysis ,Heart attack -- Drug therapy ,Warfarin -- Health aspects ,Warfarin -- Comparative analysis ,Health - Abstract
Background: After the acute coronary syndrome, adding warfarin to standard aspirin therapy decreases myocardial infarction and stroke but increases major bleeding. Purpose: To quantify the risks and benefits of warfarin therapy after the acute coronary syndrome. Data Sources: MEDLINE from 1990 to October 2004. Additional data were obtained from study authors. Clinical risk factors were used to classify hypothetical patients into cardiovascular and bleeding risk groups on the basis of published data. Study Selection: Randomized trials comparing intensive warfarin therapy (international normalized ratio > 2.0) plus aspirin with aspirin alone after the acute coronary syndrome. Data Extraction: Two reviewers independently selected studies and extracted data on study design; quality; and clinical outcomes, including myocardial infarction, stroke, revascularization, death, and major and minor bleeding. Rate ratios for outcomes were calculated and pooled by using the method of DerSimonian and Laird. Data Synthesis: Ten trials involving a total of 5938 patients (11 334 patient-years) met the study criteria. Compared with aspirin alone, warfarin plus aspirin was associated with a decrease in the annual rate of myocardial infarction (0.022 vs. 0.041; rate ratio, 0.56 [95% CI, 0.46 to 0.69]), ischemic stroke (0.004 vs. 0.008; rate ratio, 0.46 [CI, 0.27 to 0.77]), and revascularization (0.115 vs. 0.135; rate ratio, 0.80 [CI, 0.67 to 0.95]). Warfarin was associated with an increase in major bleeding (0.015 vs. 0.006; rate ratio, 2.5 [CI, 1.7 to 3.7]). Mortality did not differ. Limitations: Two large studies provided most of the data. Studies did not include coronary stenting, and results should not be applied to patients with stents. Relative risk reductions may not be consistent across risk groups. Conclusions: For patients with the acute coronary syndrome who are at low or intermediate risk for bleeding, the cardiovascular benefits of warfarin outweigh the bleeding risks.
- Published
- 2005
21. Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy
- Author
-
Rothberg, Michael B., Bellantonio, Sandra, and Rose, David N.
- Subjects
Medical care, Cost of ,Cost benefit analysis ,Amantadine ,Influenza -- Care and treatment ,Influenza -- Economic aspects ,Cost benefit analysis ,Health - Abstract
Background: Although antiviral therapy is cost-effective in adults, its cost-effectiveness in older adults has not been studied. Objective: To determine the cost-effectiveness of influenza testing and treatment strategies for older adults. Design: Cost-utility decision model. Data Sources: Clinical trials of antiviral drugs and epidemiologic data. Target Population: Noninstitutionalized adults older than 65 years of age with influenza-like illness. Time Horizon: Lifetime. Perspective: Societal. Interventions: Rapid diagnostic testing or empirical therapy with antiviral drugs. Outcome Measures: Cost per quality-adjusted life-year (QALY) saved. Results of Base-Case Analysis: Compared with no intervention, empirically treating an unvaccinated 75-year-old patient with amantadine increased life expectancy by 0.0014 QALY at a cost of $1.57, a cost-effectiveness ratio of $1129 per QALY saved. Compared with amantadine, rapid diagnostic testing followed by treatment with oseltamivir cost $5025 per QALY saved and empirical treatment with oseltamivir cost $10 296 per QALY saved. Testing and treatment strategies were less cost-effective if the patient was vaccinated, ranging from $2483 per QALY saved with amantadine to $70 300 per QALY saved with oseltamivir. Results of Sensitivity Analysis: The decision was sensitive to the probability of influenza, the efficacy of oseltamivir in preventing hospitalizations, and hospitalization and case-fatality rates. The decision was not sensitive to the probability or severity of medication side effects, the quality of life for influenza illness or hospitalization, the efficacy of antiviral therapy in shortening influenza illness, or the rapid diagnostic test characteristics. Conclusions: For unvaccinated or high-risk vaccinated patients during the influenza season, empirical oseltamivir treatment is cost-effective. For other patients, rapid diagnostic testing followed by treatment with oseltamivir is cost-effective. Empirical amantadine treatment offers a low-cost alternative if patients cannot afford oseltamivir.
- Published
- 2003
22. Bacterial coinfection in influenza pneumonia: Rates, pathogens, and outcomes
- Author
-
Bartley, Patricia S., Deshpande, Abhishek, Yu, Pei-Chun, Klompas, Michael, Haessler, Sarah D., Imrey, Peter B., Zilberberg, Marya D., and Rothberg, Michael B.
- Abstract
AbstractBackground:Evidence from pandemics suggests that influenza is often associated with bacterial coinfection. Among patients hospitalized for influenza pneumonia, we report the rate of coinfection and distribution of pathogens, and we compare outcomes of patients with and without bacterial coinfection.Methods:We included adults admitted with community-acquired pneumonia (CAP) and tested for influenza from 2010 to 2015 at 179 US hospitals participating in the Premier database. Pneumonia was identified using an International Classification of Disease, Ninth Revision, Clinical Modification(ICD-9-CM) algorithm. We used multiple logistic and gamma-generalized linear mixed models to assess the relationships between coinfection and inpatient mortality, intensive care unit (ICU) admission, length of stay, and cost.Results:Among 38,665 patients hospitalized with CAP and tested for influenza, 4,313 (11.2%) were positive. In the first 3 hospital days, patients with influenza were less likely than those without to have a positive culture (10.3% vs 16.2%; P< .001), and cultures were more likely to contain Staphylococcus aureus(34.2% vs 28.2%; P= .007) and less likely to contain Streptococcus pneumoniae(24.9% vs 31.0%; P= .008). Of S. aureusisolates, 42.8% were methicillin resistant among influenza patients versus 53.2% among those without influenza (P= .01). After hospital day 3, pathogens for both groups were similar. Bacterial coinfection was associated with increased odds of in-hospital mortality (aOR, 3.00; 95% CI, 2.17–4.16), late ICU transfer (aOR, 2.83; 95% CI, 1.98–4.04), and higher cost (risk-adjusted mean multiplier, 1.77; 95% CI, 1.59–1.96).Conclusions:In a large US inpatient sample hospitalized with influenza and CAP, S. aureuswas the most frequent cause of bacterial coinfection. Coinfection was associated with worse outcomes and higher costs.
- Published
- 2022
- Full Text
- View/download PDF
23. Treatment and Outcomes among Patients =85 Years Hospitalized with Community-Acquired Pneumonia
- Author
-
Rastogi, Radhika, Yu, Pei-Chun, Deshpande, Abhishek, Hashmi, Ardeshir Z, Herzig, Shoshana J, and Rothberg, Michael B
- Abstract
Our objective was to describe community-acquired pneumonia (CAP) among patients =85 years and compare them to patients aged 65–74. This was a retrospective cohort study. The study setting included 638 hospitals in the USA participating in the Premier database from 2010 to 2015. The study participants were 488,382 adults aged =65 years hospitalized with CAP. Patients =85 years were more likely to be white (79.8% vs 76.2%), female (58.1% vs 48.3%), and admitted with aspiration pneumonia (17.1% vs 7.0%) as compared with those aged 65–75 years. They had higher rates of dementia (30.4% vs 7.8%), but lower rates of diabetes (11.2% vs 17.6%) and chronic obstructive pulmonary disease (25.5% vs 54.7%). While Staphylococcus aureus(33.4%) was the most common pathogen across all age groups, patients aged =85 were more likely to have Escherichia colipneumonia (16.1% vs 10.7%) compared with those aged 65–74. In adjusted models, patients aged =85 had greater in-hospital mortality (OR 1.14, 95% CI 1.11 to 1.18), but were less likely to be admitted to the intensive care unit (OR 0.54, 95% CI 0.53 to 0.55) and receive mechanical ventilation (OR 0.47, 95% CI 0.46 to 0.48). They also had lower rates of acute kidney injury (OR 0.95, 95% CI 0.91 to 1.00) and Clostridium difficileinfection (OR 0.91, 95% CI 0.85 to 0.99), shorter lengths of stay (mean multiplier 0.93, 95% CI 0.92 to 0.93) and lower cost (mean multiplier 0.81, 95% CI 0.80 to 0.81), and were more likely to be discharged to a skilled nursing facility (OR 2.19, 95% CI 2.15 to 2.24) or hospice (OR 2.19, 95% CI 2.11 to 2.27). In conclusion, patients aged =85 have different comorbidities and etiologies of CAP, receive less intense treatment, and have greater mortality than patients between 65 and 75 years.
- Published
- 2022
- Full Text
- View/download PDF
24. Treatment and outcomes among patients ≥85 years hospitalized with community-acquired pneumonia
- Author
-
Rastogi, Radhika, Yu, Pei-Chun, Deshpande, Abhishek, Hashmi, Ardeshir Z, Herzig, Shoshana J, and Rothberg, Michael B
- Abstract
Our objective was to describe community-acquired pneumonia (CAP) among patients ≥85 years and compare them to patients aged 65–74. This was a retrospective cohort study. The study setting included 638 hospitals in the USA participating in the Premier database from 2010 to 2015. The study participants were 488,382 adults aged ≥65 years hospitalized with CAP. Patients ≥85 years were more likely to be white (79.8% vs 76.2%), female (58.1% vs 48.3%), and admitted with aspiration pneumonia (17.1% vs 7.0%) as compared with those aged 65–75 years. They had higher rates of dementia (30.4% vs 7.8%), but lower rates of diabetes (11.2% vs 17.6%) and chronic obstructive pulmonary disease (25.5% vs 54.7%). While Staphylococcus aureus(33.4%) was the most common pathogen across all age groups, patients aged ≥85 were more likely to have Escherichia colipneumonia (16.1% vs 10.7%) compared with those aged 65–74. In adjusted models, patients aged ≥85 had greater in-hospital mortality (OR 1.14, 95% CI 1.11 to 1.18), but were less likely to be admitted to the intensive care unit (OR 0.54, 95% CI 0.53 to 0.55) and receive mechanical ventilation (OR 0.47, 95% CI 0.46 to 0.48). They also had lower rates of acute kidney injury (OR 0.95, 95% CI 0.91 to 1.00) and Clostridium difficileinfection (OR 0.91, 95% CI 0.85 to 0.99), shorter lengths of stay (mean multiplier 0.93, 95% CI 0.92 to 0.93) and lower cost (mean multiplier 0.81, 95% CI 0.80 to 0.81), and were more likely to be discharged to a skilled nursing facility (OR 2.19, 95% CI 2.15 to 2.24) or hospice (OR 2.19, 95% CI 2.11 to 2.27). In conclusion, patients aged ≥85 have different comorbidities and etiologies of CAP, receive less intense treatment, and have greater mortality than patients between 65 and 75 years.
- Published
- 2022
- Full Text
- View/download PDF
25. Physicians' Views on Utilization of an Electronic Health Record–Embedded Calculator to Assess Risk for Venous Thromboembolism among Medical Inpatients: A Qualitative Study
- Author
-
Moss, Stephanie R., Martinez, Kathryn A., Nathan, Cassandra, Pfoh, Elizabeth R., and Rothberg, Michael B.
- Published
- 2022
- Full Text
- View/download PDF
26. Respiratory viral testing and antibacterial treatment in patients hospitalized with community-acquired pneumonia
- Author
-
Klompas, Michael, Imrey, Peter B., Yu, Pei-Chun, Rhee, Chanu, Deshpande, Abhishek, Haessler, Sarah, Zilberberg, Marya D., and Rothberg, Michael B.
- Abstract
AbstractObjective:Viruses are more common than bacteria in patients hospitalized with community-acquired pneumonia. Little is known, however, about the frequency of respiratory viral testing and its associations with antimicrobial utilization.Design:Retrospective cohort study.Setting:The study included 179 US hospitals.Patients:Adults admitted with pneumonia between July 2010 and June 2015.Methods:We assessed the frequency of respiratory virus testing and compared antimicrobial utilization, mortality, length of stay, and costs between tested versus untested patients, and between virus-positive versus virus-negative patients.Results:Among 166,273 patients with pneumonia on admission, 40,787 patients (24.5%) were tested for respiratory viruses, 94.8% were tested for influenza, and 20.7% were tested for other viruses. Viral assays were positive in 5,133 of 40,787 tested patients (12.6%), typically for influenza and rhinovirus. Tested patients were younger and had fewer comorbidities than untested patients, but patients with positive viral assays were older and had more comorbidities than those with negative assays. Blood cultures were positive for bacterial pathogens in 2.7% of patients with positive viral assays versus 5.3% of patients with negative viral tests (P< .001). Antibacterial courses were shorter for virus-positive versus -negative patients overall (mean 5.5 vs 6.4 days; P< .001) but varied by bacterial testing: 8.1 versus 8.0 days (P= .60) if bacterial tests were positive; 5.3 versus 6.1 days (P< .001) if bacterial tests were negative; and 3.3 versus 5.2 days (P< .001) if bacterial tests were not obtained (interaction P< .001).Conclusions:A minority of patients hospitalized with pneumonia were tested for respiratory viruses; only a fraction of potential viral pathogens were assayed; and patients with positive viral tests often received long antibacterial courses.
- Published
- 2021
- Full Text
- View/download PDF
27. Treatment and Outcomes of Inpatient Hypertension Among Adults With Noncardiac Admissions
- Author
-
Rastogi, Radhika, Sheehan, Megan M., Hu, Bo, Shaker, Victoria, Kojima, Lisa, and Rothberg, Michael B.
- Abstract
IMPORTANCE: Despite high prevalence of elevated blood pressure (BP) among medical inpatients, BP management guidelines are lacking for this population. The outcomes associated with intensifying BP treatment in the hospital are poorly studied. OBJECTIVES: To characterize clinician response to BP in the hospital and at discharge and to compare short- and long-term outcomes associated with antihypertensive treatment intensification. DESIGN, SETTING, AND PARTICIPANTS: This cohort study took place from January 1 to December 31, 2017, with 1 year of follow-up at 10 hospitals within the Cleveland Clinic Hospitals health care system. All adults admitted to a medicine service in 2017 were evaluated for inclusion. Patients with cardiovascular diagnoses were excluded. Demographic and BP characteristics were used for propensity matching. EXPOSURES: Acute hypertension treatment, defined as administration of an intravenous antihypertensive medication or a new class of an oral antihypertensive treatment. MAIN OUTCOMES AND MEASURES: The association between acute hypertension treatment and subsequent inpatient acute kidney injury, myocardial injury, and stroke was measured. Postdischarge outcomes included stroke and myocardial infarction within 30 days and BP control up to 1 year. RESULTS: Among 22 834 adults hospitalized for noncardiovascular diagnoses (mean [SD] age, 65.6 [17.9] years; 12 993 women [56.9%]; 15 963 White patients [69.9%]), 17 821 (78%) had at least 1 hypertensive BP recorded during their admission. Of these patients, 5904 (33.1%) were treated. A total of 8692 of 106 097 cases (8.2%) of hypertensive systolic BPs were treated; of these, 5747 (66%) were treated with oral medications. In a propensity-matched sample controlling for patient and BP characteristics, treated patients had higher rates of subsequent acute kidney injury (466 of 4520 [10.3%] vs 357 of 4520 [7.9%]; P < .001) and myocardial injury (53 of 4520 [1.2%] vs 26 of 4520 [0.6%]; P = .003). There was no BP interval in which treated patients had better outcomes than untreated patients. A total of 1645 of 17 821 patients (9%) with hypertension were discharged with an intensified antihypertensive regimen. Medication intensification at discharge was not associated with better BP control in the following year. CONCLUSIONS AND RELEVANCE: In this cohort study, hypertension was common among medical inpatients, but antihypertensive treatment intensification was not. Intensification of therapy without signs of end-organ damage was associated with worse outcomes.
- Published
- 2021
- Full Text
- View/download PDF
28. Development and internal validation of the Cleveland Clinic Bleeding Model to predict major bleeding risk at admission in medical inpatients
- Author
-
Mittman, Benjamin G., Sheehan, Megan, Kojima, Lisa, Casacchia, Nicholas J., Lisheba, Oleg, Hu, Bo, Pappas, Matthew A., and Rothberg, Michael B.
- Abstract
Guidelines recommend pharmacologic VTE prophylaxis for acutely ill medical patients at acceptable bleeding risk, but only the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) model has been validated for bleeding risk assessment.
- Published
- 2024
- Full Text
- View/download PDF
29. Variation in Patient Smoking Cessation Rates Among Health-Care Providers
- Author
-
Almaaitah, Saja, Ciemins, Elizabeth L., Joshi, Vaishali, Arora, Anupama, Meskow, Christopher, and Rothberg, Michael B.
- Abstract
Physicians play a crucial role in providing smoking cessation counseling and medications. However, it is unknown whether individual physicians’ approaches affect whether patients quit.
- Published
- 2020
- Full Text
- View/download PDF
30. Trends in pioglitazone use among U.S. adults with type 2 diabetes and suspected nonalcoholic fatty liver disease
- Author
-
Le, Phuc, Chaitoff, Alexander, Rothberg, Michael B., McCullough, Arthur, and Alkhouri, Naim
- Abstract
ABSTRACTBackground: We aimed to estimate population-based trends in the prevalence of coexisting type 2 diabetes (T2D) and suspected nonalcoholic fatty liver disease (NAFLD) and pioglitazone use among U.S. adults.Research design and methods: We conducted a cross-sectional analysis of the National Health and Nutrition Examination Survey from 2003 to 2016. We included people aged ≥18 years who had HbA1C >6.4%, fasting plasma glucose >125 mg/dL, or were told they had diabetes by a doctor. Suspected NAFLD was defined using a hepatic steatosis index of >36. Prevalence was estimated for each 2-year survey cycle. Trends were analyzed using logistic regression, accounting for the complex survey design.Results: Total sample size was 40,323 U.S. adults, of which 5690 had T2D. Age-adjusted prevalence of T2D with NAFLD increased from 5.6% in 2003–2004 to 6.8% in 2015–2016 (p-value <0.001). Pioglitazone use peaked at 20% in 2005–2006 and then declined to 4.1% in 2013–2014. Patients with suspected NAFLD were not more likely to receive pioglitazone; 3.8% of patients received the drug in 2015–2016.Conclusions: The prevalence of T2D with suspected NALFD increased among U.S. adults, but pioglitazone use decreased significantly over 2003–2016. Our study suggested a missed opportunity to prevent a future epidemic of cirrhosis due to NAFLD in patients with T2D.
- Published
- 2020
- Full Text
- View/download PDF
31. Educational Targets to Reduce Medication Errors by General Surgery Residents
- Author
-
Chaitoff, Alex, Strong, Andrew T., Bauer, Seth R., Garber, Ari, Landreneau, Joshua P., French, Judith, Rothberg, Michael B., and Lipman, Jeremy M.
- Abstract
Hospitalized patients are exposed to more than 1 medication error per day, but there are limited data concerning the factors associated with medication order errors made by general surgery residents. The objective of this study was to identify patterns in medication order errors amongst general surgery residents, which may provide educational targets to reduce medication errors by this population of providers.
- Published
- 2019
- Full Text
- View/download PDF
32. Association of Patient Characteristics and Insurance Type with Multiple Myeloma Care Patterns
- Author
-
Gasoyan, Hamlet, Anwer, Faiz, Casacchia, Nicholas J, Kovach, Jeff, Valent, Jason, and Rothberg, Michael B.
- Abstract
Background:Studies reporting disparities inmultiple myeloma (MM) care patterns are mostly limited to Medicare Parts A & B beneficiaries. Moreover, little is known about access to triplet regimens and expensive prescription oral medications such as lenalidomide.
- Published
- 2023
- Full Text
- View/download PDF
33. Postprandial Hypotension
- Author
-
Luciano, Gina L., Brennan, Maura J., and Rothberg, Michael B.
- Subjects
Hypotension -- Demographic aspects ,Hypotension -- Risk factors ,Hypotension -- Physiological aspects ,Hypotension -- Care and treatment ,Fainting -- Causes of ,Health ,Health care industry - Abstract
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.amjmed.2009.06.026 Byline: Gina L. Luciano, Maura J. Brennan, Michael B. Rothberg Keywords: Geriatric; Postprandial hypotension Abstract: Postprandial hypotension is both common in geriatric patients and an important but under-recognized cause of syncope. Other populations at risk include those with Parkinson disease and autonomic failure. The mechanism is not clearly understood, but appears to be secondary to a blunted sympathetic response to a meal. This review discusses the epidemiology, risk factors, and pathophysiology of postprandial hypotension in the elderly, as well as diagnosis and treatment strategies. Diagnosis can be made based on ambulatory blood pressure monitoring and patient symptoms. Lifestyle modifications such as increased water intake before eating or substituting 6 smaller meals daily for 3 larger meals may be effective treatment options. However, data from randomized, controlled trials are limited. Increased awareness of this disease may lead to improved quality of life, decreased falls and injuries, and the avoidance of unnecessary testing. Author Affiliation: Division of General Medicine and Geriatrics, Baystate Medical Center, Springfield, Mass; Tufts University School of Medicine, Boston, Mass Article Note: (footnote) Funding: None., Conflict of Interest: There is no financial conflict of interest for any of the authors., Authorship: All authors participated in the writing of this manuscript.
- Published
- 2010
34. Association of Adenoma and Proximal Sessile Serrated Polyp Detection Rates With Endoscopist Characteristics
- Author
-
Sarvepalli, Shashank, Garber, Ari, Rothberg, Michael B., Mankaney, Gautam, McMichael, John, Morris-Stiff, Gareth, Vargo, John J., Rizk, Maged K., and Burke, Carol A.
- Abstract
IMPORTANCE: Research demonstrates adenoma detection rate (ADR) and proximal sessile serrated polyp detection rate (pSSPDR) are associated with endoscopist characteristics including sex, specialty, and years in practice. However, many studies have not adjusted for other risk factors associated with colonic neoplasia. OBJECTIVE: To assess the association between endoscopist characteristics and polyp detection after adjusting the factors included in previous studies as well as other factors. DESIGN, SETTING, AND PARTICIPANTS: This cohort study was conducted in the Cleveland Clinic health system with data from individuals undergoing screening colonoscopies between January 2015 and June 2017. The study analyzed data using methods from previous studies that have demonstrated significant associations between endoscopist characteristics and ADR or pSSPDR. Multilevel mixed-effects logistic regression was performed to examine 7 endoscopist characteristics associated with ADRs and pSSPDRs after controlling for patient demographic, clinical, and colonoscopy-associated factors. EXPOSURES: Seven characteristics of endoscopists performing colonoscopy. MAIN OUTCOMES AND MEASURES: The ADR and pSSPDR, with a hypothesis created after data collection began. RESULTS: A total of 16 089 colonoscopies were performed in 16 089 patients by 56 clinicians. Of these, 8339 patients were male (51.8%), and the median (range) age of the cohort was 59 (52-66) years. Analyzing the data by the methods used in 4 previous studies yielded an association between endoscopist and polyp detection; surgeons (OR, 0.49 [95% CI, 0.28-0.83]) and nongastroenterologists (OR, 0.50 [95% CI 0.29-0.85]) had reduced odds of pSSPDR, which was similar to results in previous studies. In a multilevel mixed-effects logistic regression analysis, ADR was not significantly associated with any endoscopist characteristic, and pSSPDR was only associated with years in practice (odds ratio, 0.86 [95% CI, 0.83-0.89] per increment of 10 years; P < .001) and number of annual colonoscopies performed (odds ratio, 1.05 [95% CI, 1.01-1.09] per 50 colonoscopies/year; P = .02). CONCLUSIONS AND RELEVANCE: The differences in ADRs that were associated with 7 of 7 endoscopist characteristics and differences in pSSPDRs that were associated with 5 of 7 endoscopist characteristics in previous studies may have been associated with residual confounding, because they were not replicated in this analysis. Therefore, these characteristics should not influence the choice of endoscopist for colorectal cancer screening. However, clinicians further from their training and those with lower colonoscopy volumes have lower adjusted pSSPDRs and may need additional training to help increase pSSPDRs.
- Published
- 2019
- Full Text
- View/download PDF
35. Anticipated Rates and Costs of Guideline-Concordant Preoperative Stress Testing
- Author
-
Pappas, Matthew A., Sessler, Daniel I., and Rothberg, Michael B.
- Published
- 2019
- Full Text
- View/download PDF
36. Differential impact of systolic and diastolic heart failure on in-hospital treatment, outcomes, and cost of patients admitted for pneumonia
- Author
-
Halabi, Jessica El, Hariri, Essa, Pack, Quinn R., Guo, Ning, Yu, Pei-Chun, Patel, Niti G., Imrey, Peter B., and Rothberg, Michael B.
- Abstract
•Patients with systolic heart failure admitted for pneumonia had worse in-hospital outcomes compared to patients with diastolic heart failure.•There were no substantial differences in cost or length of stay between systolic and diastolic HF patients admitted for pneumonia.•Patients with systolic heart failure were frequently not prescribed heart failure treatments during hospitalization, even when they became hemodynamically stable enough to discharge home.•Among patients hospitalized for pneumonia, there is a need to optimize guideline-directed medications in systolic HF prior to discharge.
- Published
- 2023
- Full Text
- View/download PDF
37. Characteristics of Successful Internal Medicine Resident Research Projects: Predictors of Journal Publication Versus Abstract Presentation
- Author
-
Atreya, Auras R., Stefan, Mihaela, Friderici, Jennifer L., Kleppel, Reva, Fitzgerald, Janice, and Rothberg, Michael B.
- Abstract
Supplemental Digital Content is available in the text.
- Published
- 2018
- Full Text
- View/download PDF
38. Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
- Author
-
Le, Phuc and Rothberg, Michael B.
- Abstract
IMPORTANCE: The live attenuated herpes zoster vaccine (ZVL) is recommended for immunocompetent adults 60 years or older, but the efficacy wanes with age and over time. A new adjuvanted herpes zoster subunit vaccine (HZ/su) has higher efficacy but might be more expensive. The choice of vaccines depends on their relative values. OBJECTIVE: To assess the cost-effectiveness of HZ/su. DESIGN, SETTING, AND PARTICIPANTS: Markov decision model with transition probabilities based on the US medical literature. Participants were immunocompetent adults 60 years or older. Data were derived from participant groups ranging in number from less than 100 to more than 30 000 depending on the variable assessed. The study dates were July 1 to 31, 2017. EXPOSURES: No vaccination, ZVL (single dose), and HZ/su (2-dose series) vaccine administered at different ages. MAIN OUTCOMES AND MEASURES: Total costs and quality-adjusted life-years (QALYs) were estimated. RESULTS: Based on randomized clinical trial data, at a price of $280 per series ($140 per dose), HZ/su was more effective and less expensive than ZVL at all ages. The incremental cost-effectiveness ratios compared with no vaccination ranged from $20 038 to $30 084 per QALY, depending on vaccination age. The finding was insensitive to variations in most model inputs other than the vaccine price and certain combinations of low adherence rate with a second dose and low efficacy of a single dose of HZ/su. At the current ZVL price ($213 per dose), HZ/su had lower overall costs than ZVL up to a price of $350 per 2-dose series. In probabilistic sensitivity analysis, HZ/su had 73% probability of being cost-effective for 60-year-olds at $50 000 per QALY. CONCLUSIONS AND RELEVANCE: Under conservative assumptions, at a price of $280 per series ($140 per dose), HZ/su would cost less than ZVL and has a high probability of offering good value.
- Published
- 2018
- Full Text
- View/download PDF
39. Thromboembolic and Major Bleeding Events With Rivaroxaban Versus Warfarin Use in a Real-World Setting
- Author
-
Russo-Alvarez, Giavanna, Martinez, Kathryn A., Valente, Megan, Bena, James, Hu, Bo, Luxenburg, Jennifer, Chaitoff, Alexander, Ituarte, Catherine, Brateanu, Andrei, and Rothberg, Michael B.
- Abstract
Background:Although randomized trials demonstrate the noninferiority of rivaroxaban compared with warfarin in the context of nonvalvular atrial fibrillation (AF), little is known about how these drugs compare in practice. Objective:To assess the relative effectiveness and safety of rivaroxaban versus warfarin in a large health system and to evaluate this association by time in therapeutic range (TTR). Methods:We conducted a retrospective cohort study with propensity matching in the Cleveland Clinic Health System. The study included patients initiated on warfarin or rivaroxaban for thromboembolic prevention in nonvalvular AF between January 2012 and July 2016. The main outcomes were thromboembolic events and major bleeds. Analyses were stratified by warfarin patients’ TTR. Results:The cohort consisted of 472 propensity-matched pairs. The mean age was 73.6 years (SD = 11.7), and the mean CHADS2score was 1.8. The median TTR for warfarin patients was 64%. In the propensity-matched analysis, there was no significant difference in thromboembolic or major bleeding events between groups. Among warfarin patients with a TTR <64% and their matched rivaroxaban pairs, there was also no significant difference in thromboembolic or major bleeding events. Conclusions:Under real-world conditions, warfarin and rivaroxaban were associated with similar safety and effectiveness, even among those with suboptimal therapeutic control. Individualized decision making, taking into account the nontherapeutic tradeoffs associated with these medications (eg, monitoring, half-life, cost) is warranted.
- Published
- 2018
- Full Text
- View/download PDF
40. Associations Between Physician Empathy, Physician Characteristics, and Standardized Measures of Patient Experience
- Author
-
Chaitoff, Alexander, Sun, Bob, Windover, Amy, Bokar, Daniel, Featherall, Joseph, Rothberg, Michael B., and Misra-Hebert, Anita D.
- Published
- 2017
- Full Text
- View/download PDF
41. Phantom vibration syndrome among medical staff
- Author
-
Rothberg, Michael B., Arora, Ashish, Hermann, Jodie, Kleppel, Reva, St Marie, Peter, and Visintainer, Paul
- Subjects
Wireless telecommunications equipment -- Usage ,Medical personnel -- Health aspects ,Prevalence studies (Epidemiology) ,Wireless telecommunications equipment - Published
- 2010
42. Working Despite Having Influenza-Like Illness: Results of An Anonymous Survey of Healthcare Providers Who Care for Transplant Recipients
- Author
-
Mossad, Sherif B., Deshpande, Abhishek, Schramm, Sarah, Liu, Xiaobo, and Rothberg, Michael B.
- Abstract
OBJECTIVETo compare the rates of and reasons for presenteeism associated with influenza-like illness (ILI) among healthcare professionals (HCPs) caring for hospitalized inpatient transplant recipients and internal medicine patients.DESIGNWe designed a 10-question anonymous survey in which ILI was defined as fever (>37.8°C) and cough and/or sore throat and ILI B was defined as fever (>37.8°C) or cough or sore throat; both definitions were considered in the absence of another known cause.SETTINGTertiary-care center.PARTICIPANTSPhysicians, advanced practice providers (APPs) and nurses.INTERVENTIONSurvey deployed at peak of influenza activity in 2016.MEASUREMENTSRates of ILI, presenteeism, wearing masks, and time away due to ILI.RESULTSOf 707 HCPs surveyed, 286 (40%) responded; 15 (5.2%) reported having ILI, and 73 (25.5%) reported having ILI B in the preceding 2 weeks. Presenteeism rates were 92% in both groups of HCPs and were higher among women (adjusted odds ratio [AOR], 2.64; 95% CI, 1.23–5.71; P=.01) and those ≤40 years old (AOR, 1.92; 95% CI, 1.03–3.68; P=.04). Healthcare professionals who cared for transplant recipients and female HCPs were more likely to wear masks (AOR, 2.13; 95% CI, 1.05–3.40; P=.04 for transplant recipients and AOR, 3.96; 95% CI, 1.35–11.63; P=.01 for female HCPs). Nurses were more likely than physicians and APPs to take time off (AOR, 3.33; 95% CI, 1.10–10.09; P=.03.)CONCLUSIONSPresenteeism among HCPs with ILI is common, including among those caring for transplant recipients. Nonpunitive systems should encourage HCPs not to work with ILI and to wear masks to prevent spread of infections.Infect Control Hosp Epidemiol2017;38:966–969
- Published
- 2017
- Full Text
- View/download PDF
43. Development of an Ambulatory Clinical Pharmacy Prioritization Prediction Model for Patients With Diabetes
- Author
-
Lam, Simon W., Russo-Alvarez, Giavanna, Cristiani, Cari, and Rothberg, Michael B.
- Abstract
Background:Health care reform and the projected shortage of primary care physicians necessitate more efficient use of multidisciplinary collaboration. No studies, to date, have evaluated factors associated with treatment success among patients referred to a clinical pharmacist. Objective:To develop a prediction model using patient factors to assist in selecting patients with diabetes most likely to benefit from pharmacy interventions. Methods:A retrospective, nested case-control study was performed. A prediction model using multivariable logistic regression was developed, with model calibration and internal validation. Adult patients with diabetes who had a baseline hemoglobin A1C(A1C) ≥9%, who were consulted for collaborative pharmacy care between July 2009 and July 2014 were included. Success (cases) was defined as a decrease in A1C by 2% or a value of A1C <8% 1 year after the initial visit. Failures were those who did not achieve the A1C goal or were lost to follow-up. Results:A total of 544 unique patients were included, with 243 (44.7%) classified as clinical successes and 301 as clinical failures. Independent factors associated with success included past medical history of cerebrovascular accident and higher baseline A1C, whereas use of short-acting insulin and higher number of classes of diabetic medications at baseline corresponded with failure. A prediction model for success using these factors had an optimism-adjusted C-statistics of 0.629, with good calibration. Conclusion:Referred patients with diabetes have baseline characteristics that are predictive of clinical success. A predictive model based on those factors performed well and might be utilized to improve pharmacist efficiency in the face of constrained resources.
- Published
- 2017
- Full Text
- View/download PDF
44. Prospective Correlation between Likelihood of Favorable Pathology on the 17-Gene Genomic Prostate Score and Actual Pathological Outcomes at Radical Prostatectomy
- Author
-
Whalen, Michael J., Hackert, Victoria, Rothberg, Michael B., McKiernan, James M., Benson, Mitchell C., and Badani, Ketan K.
- Abstract
We evaluate the Genomic Prostate Score in a prospective clinical setting and determine the cutoff point for likelihood of favorable pathology, below which definitive treatment should be advised.
- Published
- 2016
- Full Text
- View/download PDF
45. Association Between Antibiotic Prescribing for Respiratory Tract Infections and Patient Satisfaction in Direct-to-Consumer Telemedicine
- Author
-
Martinez, Kathryn A., Rood, Mark, Jhangiani, Nikhyl, Kou, Lei, Boissy, Adrienne, and Rothberg, Michael B.
- Published
- 2018
- Full Text
- View/download PDF
46. Characteristics and Outcomes of Patients Presenting With Hypertensive Urgency in the Office Setting
- Author
-
Patel, Krishna K., Young, Laura, Howell, Erik H., Hu, Bo, Rutecki, Gregory, Thomas, George, and Rothberg, Michael B.
- Abstract
IMPORTANCE: The prevalence and short-term outcomes of hypertensive urgency (systolic blood pressure ≥180 mm Hg and/or diastolic blood pressure ≥110 mm Hg) are unknown. Guidelines recommend achieving blood pressure control within 24 to 48 hours. However, some patients are referred to the emergency department (ED) or directly admitted to the hospital, and whether hospital management is associated with better outcomes is unknown. OBJECTIVES: To describe the prevalence of hypertensive urgency and the characteristics and short-term outcomes of these patients, and to determine whether referral to the hospital is associated with better outcomes than outpatient management. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study with propensity matching included all patients presenting with hypertensive urgency to an office in the Cleveland Clinic Healthcare system from January 1, 2008, to December 31, 2013. Pregnant women and patients referred to the hospital for symptoms or treatment of other conditions were excluded. Final follow-up was completed on June 30, 2014, and data were assessed from October 31, 2014, to May 31, 2015. EXPOSURES: Hospital vs ambulatory blood pressure management. MAIN OUTCOMES AND MEASURES: Major adverse cardiovascular events (MACE) consisting of acute coronary syndrome and stroke or transient ischemic attack, uncontrolled hypertension (≥140/90 mm Hg), and hospital admissions. RESULTS: Of 2 199 019 unique patient office visits, 59 836 (4.6%) met the definition of hypertensive urgency. After excluding 851 patients, 58 535 were included. Mean (SD) age was 63.1 (15.4) years; 57.7% were women; and 76.0% were white. Mean (SD) body mass index (calculated as weight in kilograms divided by height in meters squared) was 31.1 (7.6); mean (SD) systolic blood pressure, 182.5 (16.6) mm Hg; and mean (SD) diastolic blood pressure, 96.4 (15.8) mm Hg. In the propensity-matched analysis, the 852 patients sent home were compared with the 426 patients referred to the hospital, with no significant difference in MACE at 7 days (0 vs 2 [0.5%]; P = .11), 8 to 30 days (0 vs 2 [0.5%]; P = .11), or 6 months (8 [0.9%] vs 4 [0.9%]; P > .99). Patients sent home were more likely to have uncontrolled hypertension at 1 month (735 of 852 [86.3%] vs 349 of 426 [81.9%]; P = .04) but not at 6 months (393 of 608 [64.6%] vs 213 of 320 [66.6%]; P = .56). Patients sent home had lower hospital admission rates at 7 days (40 [4.7%] vs 35 [8.2%]; P = .01) and at 8 to 30 days (59 [6.9%] vs 48 [11.3%]; P = .009). CONCLUSIONS AND RELEVANCE: Hypertensive urgency is common, but the rate of MACE in asymptomatic patients is very low. Visits to the ED were associated with more hospitalizations, but not improved outcomes. Most patients still had uncontrolled hypertension 6 months later.
- Published
- 2016
- Full Text
- View/download PDF
47. Probability of developing proximal deep-vein thrombosis and/or pulmonary embolism after distal deep-vein thrombosis
- Author
-
Brateanu, Andrei, Patel, Krishna, Chagin, Kevin, Tunsupon, Pichapong, Yampikulsakul, Pojchawan, Shah, Gautam V., Wangsiricharoen, Sintawat, Amah, Linda, Allen, Joshua, Shapiro, Aryeh, Gupta, Neha, Morgan, Lillie, Kumar, Rahul, Nielsen, Craig, and Rothberg, Michael B.
- Published
- 2016
- Full Text
- View/download PDF
48. Correlates and Outcomes of Physician Burnout Within a Large Academic Medical Center
- Author
-
Windover, Amy K., Martinez, Kathryn, Mercer, Mary Beth, Neuendorf, Katie, Boissy, Adrienne, and Rothberg, Michael B.
- Published
- 2018
- Full Text
- View/download PDF
49. Acute but not chronic heart failure is associated with higher mortality among patients hospitalized with pneumonia: An analysis of a nationwide database
- Author
-
Hariri, Essa, Patel, Niti G., Bassil, Elias, Matta, Milad, Yu, Pei-Chun, Pack, Quinn R., and Rothberg, Michael B.
- Abstract
Among patients admitted for pneumonia, heart failure (HF) is associated with worse outcomes. It is unclear whether this association is due to acute HF exacerbations, complex medical management, or chronic co-morbid conditions.
- Published
- 2022
- Full Text
- View/download PDF
50. Informed Decision Making for Percutaneous Coronary Intervention for Stable Coronary Disease
- Author
-
Rothberg, Michael B., Sivalingam, Senthil K., Kleppel, Reva, Schweiger, Marc, Hu, Bo, and Sepucha, Karen R.
- Abstract
IMPORTANCE: Patients with stable coronary disease undergoing percutaneous coronary intervention (PCI) are frequently misinformed about the benefits of PCI. Little is known about the quality of decision making before angiography and possible PCI. OBJECTIVE: To assess the quality of informed decision making and its association with patient decisions. DESIGN, SETTING, AND PARTICIPANTS: We performed a cross-sectional analysis of recorded conversations between August 1, 2008, and August 31, 2012, among adults with known or suspected stable coronary disease at outpatient cardiology practices. MAIN OUTCOMES AND MEASURES: Presence of 7 elements of informed decision making and the decision to undergo angiography and possible PCI. RESULTS: Of 59 conversations conducted by 23 cardiologists, 2 (3%) included all 7 elements of informed decision making; 8 (14%) met a more limited definition of procedure, alternatives, and risks. Specific elements significantly associated with not choosing angiography and possible PCI included discussion of uncertainty (odds ratio [OR], 20.5; 95% CI, 2.3-204.9), patient’s role (OR, 5.3; 95% CI, 1.3-21.3), exploration of alternatives (OR, 9.5; 95% CI, 2.5-36.5), and exploration of patient preference (OR, 4.8; 95% CI, 1.2-19.4). Neither the presence of angina nor severity of symptoms was associated with choosing angiography and possible PCI. In a multivariable analysis using the total number of elements as a predictor, better informed patients were less likely to choose angiography and possible PCI (OR per additional element, 3.2; 95% CI, 1.4-7.1; P = .005). CONCLUSIONS AND RELEVANCE: In conversations between cardiologists and patients with stable angina, informed decision making is often incomplete. More complete discussions are associated with patients choosing not to undergo angiography and possible PCI.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.